Filing Details
- Accession Number:
- 0001104659-22-063844
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-23 16:05:46
- Reporting Period:
- 2022-05-20
- Accepted Time:
- 2022-05-23 16:05:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1297184 | Amphastar Pharmaceuticals Inc. | AMPH | Pharmaceutical Preparations (2834) | 330702205 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1611156 | Z. Mary Luo | C/O Amphastar Pharmaceuticals, Inc. 11570 6Th Street Rancho Cucamonga CA 91730 | Ceo & Chief Scientific Officer | Yes | Yes | Yes | No |
| 1611157 | Y. Jack Zhang | C/O Amphastar Pharmaceuticals, Inc. 11570 6Th Street Rancho Cucamonga CA 91730 | Ceo & Chief Scientific Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-05-20 | 10,650 | $34.21 | 2,104,143 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,498,519 | Indirect | See footnote |
| Common Stock | 6,827,679 | Indirect | See footnote |
| Common Stock | 5,000 | Indirect | See footnote |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2021.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.68 to $34.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife.
- The shares are held of record by Applied Physics & Chemistry Laboratories, Inc., of which the reporting persons and The Bill Luobei Zhang 2004 Irrevocable Trust are the sole owners.
- The shares are held of record in an account for the benefit of the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.
Billionaire Hedge Funds
